Pfizer

US FDA orders Pfizer to test second Paxlovid course for rebound COVID patients

Read more

Pfizer MD Sridhar puts down papers

Read more

Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare haematology

Read more

Pfizer to discontinue development programme for PF-07265803 for LMNA-related dilated cardiomyopathy

Read more

Pfizer and BioNTech’s COVID-19 vaccine Comirnaty tops the list of best-selling drugs

Read more

Pfizer to buy 8.1 per cent stake in Valneva

Read more

EU drugs watchdog begins review of Moderna’s variant COVID vaccine

Read more

Pfizer to spend $120 million to boost US COVID pill manufacturing

Read more

Myovant Sciences and Pfizer announce US FDA acceptance of supplemental NDA for Myfembree

Read more

Canada authorises Pfizer COVID-19 booster for 16 and 17-year-olds

Read more